{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-24-000143","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.853399+00:00","generated_at":"2026-05-30T10:36:52.146160+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GRI Bio raises $13.9M in gross proceeds since Jan 2024; cash runway into mid Q1 2025","bullets":["Closed Oct 22 warrant exercise for 762,236 shares raising $0.8M gross proceeds.","Total gross proceeds since start of 2024 are approximately $13.9M.","Cash runway estimated into mid Q1 2025, supporting Phase 2a interim data for GRI-0621 (IPF).","Issued new Series D-1 and D-2 warrants with exercise price of $1.00 per share.","H.C. Wainwright acted as exclusive placement agent for the offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-24-000143","json":"https://secwatch.observer/filing/0001824293-24-000143.json","markdown":"https://secwatch.observer/filing/0001824293-24-000143.md","text":"https://secwatch.observer/filing/0001824293-24-000143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000143/0001824293-24-000143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000143/val-20241024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:36:52.146160+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}